AI assistant
Sending…
Perspective Therapeutics, Inc. — Director's Dealing 2012
Jul 16, 2012
33510_dirs_2012-07-16_3a18e73b-4ed7-46f9-b9c9-e5f35574712a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IsoRay, Inc. (ISR)
CIK: 0000728387
Period of Report: 2012-07-06
Reporting Person: Ragle Brien (Controller)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-07-06 | Common Stock | M | 11334 | $0.26 | Acquired | 11334 | Direct |
| 2012-07-06 | Common Stock | S | 400 | $0.9901 | Disposed | 10934 | Direct |
| 2012-07-06 | Common Stock | S | 10934 | $0.99 | Disposed | 0 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-07-06 | Stock Options | $0.26 | M | 11334 | Acquired | 2019-06-01 | Common Stock (11334) | Direct |
More from Perspective Therapeutics, Inc.
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 21
Major Shareholding Notification
2026
May 12
Interim / Quarterly Report
2026
May 11
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 4
Major Shareholding Notification
2026
Apr 27
Regulatory Filings
2026
Apr 20
Proxy Solicitation & Information Statement
2026
Apr 16
Proxy Solicitation & Information Statement
2026
Apr 16